Evan Seigerman
Stock Analyst at BMO Capital
(4.76)
# 629
Out of 4,704 analysts
1065
Total ratings
59.9%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Downgraded: Hold | $450 | $432.42 | +4.07% | 71 | Sep 8, 2026 | |
| BNTX BioNTech SE | Downgraded: Hold | $128 → $105 | $102.08 | +2.87% | 17 | Sep 8, 2026 | |
| ABBV AbbVie | Maintained: Buy | $300 | $255.48 | +17.43% | 28 | Sep 4, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,174.61 | +19.19% | 121 | Sep 1, 2026 | |
| INCY Incyte | Maintained: Hold | $130 | $124.37 | +4.53% | 55 | Sep 1, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $178 | $144.33 | +23.33% | 6 | Aug 31, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $174 | $145.68 | +19.44% | 81 | Aug 27, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $76 | $57.80 | +31.49% | 11 | Aug 21, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $142 → $170 | $148.35 | +14.59% | 50 | Aug 20, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Buy | $319 | $247.91 | +28.68% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 | $66.58 | -9.88% | 69 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $190 | $154.06 | +23.33% | 48 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 | $45.61 | +3.05% | 55 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $27.96 | +7.30% | 56 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $800 | $794.19 | +0.73% | 79 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $541.69 | +10.76% | 71 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $15.50 | +29.03% | 34 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $19.70 | +21.83% | 19 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $11.35 | +32.16% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 → $43.00 | $31.87 | +34.92% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $47.37 | +206.10% | 21 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $29.11 | +23.67% | 10 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $196 → $208 | $218.50 | -4.81% | 63 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $12.60 | +58.73% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $5.77 | +142.63% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $80.03 | +24.95% | 30 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.58 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.18 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.85 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €113.93 → €129.47 | €140.25 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.07 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.66 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $5.34 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 → $15 | $16.30 | n/a | 6 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €135.00 → €129.00 | €25.02 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $1.20 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $4.13 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $169 → $220 | $28.74 | n/a | 2 | Feb 24, 2020 |
Amgen
Sep 8, 2026
Downgraded: Hold
Price Target: $450
Current: $432.42
Upside: +4.07%
BioNTech SE
Sep 8, 2026
Downgraded: Hold
Price Target: $128 → $105
Current: $102.08
Upside: +2.87%
AbbVie
Sep 4, 2026
Maintained: Buy
Price Target: $300
Current: $255.48
Upside: +17.43%
Eli Lilly and Company
Sep 1, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,174.61
Upside: +19.19%
Incyte
Sep 1, 2026
Maintained: Hold
Price Target: $130
Current: $124.37
Upside: +4.53%
Protagonist Therapeutics
Aug 31, 2026
Maintained: Buy
Price Target: $178
Current: $144.33
Upside: +23.33%
Gilead Sciences
Aug 27, 2026
Maintained: Buy
Price Target: $174
Current: $145.68
Upside: +19.44%
Scholar Rock Holding
Aug 21, 2026
Maintained: Buy
Price Target: $76
Current: $57.80
Upside: +31.49%
Merck & Co.
Aug 20, 2026
Reiterated: Buy
Price Target: $142 → $170
Current: $148.35
Upside: +14.59%
Ascendis Pharma
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $319
Current: $247.91
Upside: +28.68%
Aug 17, 2026
Maintained: Hold
Price Target: $60
Current: $66.58
Upside: -9.88%
Aug 17, 2026
Maintained: Hold
Price Target: $190
Current: $154.06
Upside: +23.33%
Aug 17, 2026
Maintained: Hold
Price Target: $47
Current: $45.61
Upside: +3.05%
Aug 17, 2026
Maintained: Buy
Price Target: $30
Current: $27.96
Upside: +7.30%
Aug 17, 2026
Maintained: Buy
Price Target: $800
Current: $794.19
Upside: +0.73%
Aug 17, 2026
Maintained: Buy
Price Target: $600
Current: $541.69
Upside: +10.76%
Aug 17, 2026
Reiterated: Buy
Price Target: $20
Current: $15.50
Upside: +29.03%
Aug 17, 2026
Maintained: Buy
Price Target: $24
Current: $19.70
Upside: +21.83%
Aug 17, 2026
Maintained: Buy
Price Target: $15
Current: $11.35
Upside: +32.16%
Aug 12, 2026
Reiterated: Buy
Price Target: $39.00 → $43.00
Current: $31.87
Upside: +34.92%
Aug 6, 2026
Maintained: Buy
Price Target: $145
Current: $47.37
Upside: +206.10%
Aug 4, 2026
Maintained: Buy
Price Target: $36
Current: $29.11
Upside: +23.67%
Jul 30, 2026
Reiterated: Hold
Price Target: $196 → $208
Current: $218.50
Upside: -4.81%
Jul 27, 2026
Maintained: Buy
Price Target: $20
Current: $12.60
Upside: +58.73%
Jun 30, 2026
Maintained: Buy
Price Target: $14
Current: $5.77
Upside: +142.63%
Jun 2, 2026
Maintained: Buy
Price Target: $100
Current: $80.03
Upside: +24.95%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $36.58
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $9.18
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $3.85
Upside: n/a
Oct 23, 2024
Maintained: Buy
Price Target: €113.93 → €129.47
Current: €140.25
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $13.07
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $6.66
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $30 → $27
Current: $5.34
Upside: n/a
Dec 16, 2020
Upgraded: Buy
Price Target: $9 → $15
Current: $16.30
Upside: n/a
Oct 16, 2020
Maintained: Hold
Price Target: €135.00 → €129.00
Current: €25.02
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $1.20
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $4.13
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $169 → $220
Current: $28.74
Upside: n/a